VisEn Medical expands FMT imaging platform

VisEn Medical Inc., a leader in fluorescence imaging solutions from research through medicine, announced today that it has expanded its leading FMT imaging platform with an FMT Multi-Species Imaging Module, to extend FMT imaging and related applications into larger preclinical animal models.  VisEn also announced that it will be presenting new study results from its recently-launched Cat B 750 FAST™ and Annexin-Vivo™ fluorescence imaging agents at the AACR (American Association of Cancer Research) 101st Annual Meeting, highlighting translational imaging advances in leading oncology research.  The AACR Annual Meeting is being held in Washington, DC from April 17 – 21, 2010.


VisEn Medical Inc.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Wearable skin patch could help clinicians diagnose tumors, organ malfunction and more